Ocean Bio-Chem logo
Ocean Bio-Chem OBCI

Quarterly report 2022-Q2
added 12-23-2023

report update icon

Ocean Bio-Chem Financial Statements 2011-2025 | OBCI

Annual Financial Statements Ocean Bio-Chem

2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011

Market Cap

82.4 M 98.2 M 46.2 M 33 M 38.8 M 34.9 M 18.8 M 42.4 M 25.3 M 19.6 M 17.5 M

Shares

9.49 M 9.46 M 9.39 M 9.28 M 9.19 M 9.06 M 8.94 M 8.83 M 8.54 M 8.23 M 7.95 M

Historical Prices

8.69 10.4 4.92 3.56 3.71 3.96 1.83 4.61 2.64 2.22 2.44

Net Income

8.4 M 9.62 M 3.5 M 2.8 M 2.6 M 2.1 M 461 K 2.05 M 1.46 M 1.96 M 2.39 M

Revenue

64.3 M 55.6 M 42.3 M 41.8 M 38.9 M 36.2 M 34 M 33.9 M 32.7 M 31 M 31.7 M

Cost of Revenue

40 M 32.1 M 26.7 M 27.4 M 695 K 22.3 M - - - - -

Gross Profit

24.3 M 23.5 M 15.6 M 14.4 M 14.5 M 13.9 M 11.3 M 12.1 M 10.9 M 10.6 M 10.7 M

Operating Income

10.9 M 12.2 M 4.61 M 3.71 M 3.68 M 3.1 M 750 K 3.02 M 2.31 M 3.08 M 3.71 M

Interest Expense

149 K 132 K 119 K 122 K -2.06 K 17.8 K 33.6 K 43.5 K 67.2 K 98 K 150 K

EBITDA

12.3 M 13.5 M 5.9 M 4.88 M 4.63 M 4.07 M 1.67 M 3.87 M 3.09 M 3.78 M 4.47 M

Operating Expenses

13.4 M 11.3 M 11 M 10.7 M 10.8 M 10.8 M 10.6 M 9.11 M 8.58 M 7.54 M 6.97 M

General and Administrative Expenses

9.41 M - - - 7.3 M 7.66 M 7.58 M 6.54 M 5.93 M 5.13 M 4.99 M

All numbers in USD currency

Quarterly Income Statement Ocean Bio-Chem

2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1

Shares

- - 9.51 M 9.51 M 9.5 M 9.49 M 9.48 M 9.48 M 9.48 M 9.46 M 9.46 M 9.44 M 9.44 M 9.39 M 9.37 M 9.36 M 9.34 M 9.27 M 9.26 M 9.25 M 9.25 M 9.22 M 9.15 M 9.15 M 9.15 M 9.1 M 9.01 M 8.99 M - 8.94 M 8.92 M 8.92 M - 8.91 M 8.82 M 8.69 M - 8.61 M 8.49 M 8.4 M - 8.29 M 8.2 M 8.11 M - 8 M 7.9 M 7.85 M

Net Income

- - -321 K 1.3 M - 3.27 M 2.6 M 1.9 M - 4.66 M 3.45 M 627 K - 1.12 M 1.01 M 715 K - 1.27 M 1.12 M 523 K - 854 K 953 K 504 K - 1.53 M 657 K -541 K - 296 K 114 K -15.9 K - 903 K 411 K 224 K - 622 K 173 K 349 K - 771 K 363 K 364 K - 1.14 M 389 K 648 K

Revenue

- - - 12.7 M - 21.5 M 15.7 M 13.1 M - 19.2 M 15.7 M 7.82 M - 12.5 M 10.9 M 9.08 M - 13.2 M 11.4 M 8.38 M - 11.7 M 9.9 M 8.22 M - 12.2 M 8.72 M 6.75 M - 10.8 M 8.74 M 6 M - 10.4 M 8.81 M 5.92 M - 10.4 M 8.18 M 6.31 M - 10.3 M 7.88 M 6 M - 9.88 M 8.22 M 6.73 M

Cost of Revenue

- - 9.86 M 8 M - 14 M 8.42 M 7.75 M - 10.4 M 7.99 M 4.68 M - 8.1 M 6.43 M 5.66 M - 8.67 M 6.74 M 5.41 M - 7.52 M 5.57 M 5.24 M - 7.31 M 5.05 M 4.37 M - 7.27 M 5.57 M 3.97 M - 6.84 M - - - - - - - - - - - - - -

Gross Profit

- - 5.35 M 4.74 M - 7.45 M 7.27 M 5.38 M - 8.75 M 7.71 M 3.14 M - 4.41 M 4.52 M 3.42 M - 4.51 M 4.65 M 2.98 M - 3.81 M 4.06 M 2.98 M - 4.9 M 3.67 M 2.38 M - 3.56 M 3.16 M 2.04 M - 3.59 M 3.43 M 2.09 M - 3.18 M 2.97 M 2.24 M - 3.26 M 2.86 M 2.14 M - 3.35 M 2.98 M 2.51 M

Operating Income

- - -329 K 1.66 M - 4.21 M 3.37 M 2.47 M - 5.99 M 4.4 M 691 K - 1.47 M 1.33 M 954 K - 1.68 M 1.47 M 672 K - 1.26 M 1.4 M 742 K - 2.21 M 1.01 M -820 K - 447 K 176 K -769 - 1.34 M 582 K 352 K - 996 K 274 K 525 K - 1.18 M 620 K 621 K - 1.63 M 647 K 1.03 M

Interest Expense

- - 79.1 K 31.7 K - 35.8 K 40.8 K 37.2 K - 39.6 K 38.2 K 15.9 K - 31.2 K 35.4 K 29.8 K - 52.9 K 33.7 K -7.39 K - 259 942 1.95 K - 3.93 K 4.91 K 5.88 K - 7.89 K 8.82 K 10.1 K - 10.3 K 10.1 K 11.4 K - 16.2 K 18.2 K 17.4 K - 22.1 K 25.8 K 27.7 K - 34.8 K 47.4 K 25.8 K

EBITDA

- - -329 K 2.07 M - 4.51 M 3.66 M 2.82 M - 7.01 M 5.08 M 1.02 M - 2.44 M 1.98 M 1.28 M - 2.53 M 1.99 M 911 K - 1.99 M 1.89 M 989 K - 2.94 M 1.5 M -573 K - 1.13 M 622 K 221 K - 1.96 M 989 K 553 K - 1.58 M 650 K 711 K - 1.7 M 966 K 793 K - 2.21 M 1.07 M 1.25 M

Operating Expenses

- - - 3.07 M - 3.25 M 3.91 M 2.91 M - 2.75 M 3.3 M 2.45 M - 2.93 M 3.19 M 2.47 M - 2.83 M 3.18 M 2.31 M - 2.55 M 2.66 M 2.23 M - 2.69 M 2.66 M 3.2 M - 3.12 M 2.99 M 2.04 M - 2.26 M 2.85 M 1.74 M - 2.19 M 2.7 M 1.72 M - 2.09 M 2.25 M 1.52 M - 1.72 M 2.33 M 1.48 M

General and Administrative Expenses

- - - 2 M - 2.29 M 2.64 M 1.97 M - 2.03 M 2.5 M 1.71 M - 2.15 M 2.21 M 1.7 M - 2.11 M 2.29 M 1.55 M - 2.01 M 1.98 M 1.54 M - 1.91 M 1.79 M 2.49 M - 2.35 M 2.06 M 1.42 M - 1.62 M 2.13 M 1.15 M - 1.55 M 1.88 M 1.15 M - 1.31 M 1.6 M 1.06 M - 1.24 M 1.67 M 1.1 M

All numbers in USD currency

Financial statements are the primary tool companies use to inform stakeholders about their financial position, performance, and changes in capital structure. It is a kind of "business language" understood by investors, creditors, tax authorities, and other participants in the economic environment.

Main types of financial statements Ocean Bio-Chem OBCI
  1. Income Statement
    Shows income, expenses, and resulting profit or loss over a specific period. Helps assess business profitability.
  2. Balance Sheet
    Reflects a company’s assets, liabilities, and equity as of a specific date. It’s a snapshot of what the company owns and owes.
    Assets — everything the company owns (cash, equipment, buildings, accounts receivable, etc.).
    Liabilities — debts and other external sources of financing.
    Equity — owners' capital and retained earnings.
  3. Cash Flow Statement
    Reveals how the company earns and spends money in three areas: operating, investing, and financing activities.
International reporting standards
  • IFRS — International Financial Reporting Standards, applicable to public and multinational companies.
  • GAAP — Generally Accepted Accounting Principles used in the United States.
  • RAS — Russian Accounting Standards, used domestically in Russia.

Financial reporting Ocean Bio-Chem plays a crucial role for investors as it serves as an objective source of information about a company's current state. Based on the reports, one can determine whether a company is growing, stagnating, or losing market share. This allows investors to identify both promising and problematic assets in a timely manner.

In addition, financial data provides a basis for forecasting future returns. Historical trends in revenue, profit, and cash flow help evaluate potential dividends, the likelihood of stock price growth, and overall investment risk.

Transparent and accurate reporting is also an indicator of a company’s maturity and managerial responsibility. Such openness builds investor confidence and simplifies investment decision-making, especially when comparing multiple companies.

Finally, financial statements enable high-quality comparative analysis. They allow companies to be evaluated against each other in terms of profitability, debt levels, margins, and other key metrics — which is particularly important when choosing the best investment options within an industry or market segment.

Financial statements of other stocks in the Conglomerates industry

Issuer Price % 24h Market Cap Country
Cemtrex Cemtrex
CETX
$ 3.08 -11.52 % $ 1.26 M usaUSA
SGOCO Group, Ltd. SGOCO Group, Ltd.
SGOC
- -0.32 % $ 718 M chinaChina
Alpha Metallurgical Resources Alpha Metallurgical Resources
AMR
$ 183.71 -3.27 % $ 2.39 B usaUSA
Icahn Enterprises L.P. Icahn Enterprises L.P.
IEP
$ 7.74 -0.39 % $ 4.65 B usaUSA
India Globalization Capital India Globalization Capital
IGC
$ 0.34 6.16 % $ 26 M usaUSA
Matthews International Corporation Matthews International Corporation
MATW
$ 26.68 -1.93 % $ 830 M usaUSA
NN NN
NNBR
$ 1.27 6.72 % $ 59.4 M usaUSA
Compass Diversified Compass Diversified
CODI
$ 5.21 -3.43 % $ 392 M usaUSA
Seaboard Corporation Seaboard Corporation
SEB
$ 4 419.0 0.12 % $ 4.29 B usaUSA
Steel Partners Holdings L.P. Steel Partners Holdings L.P.
SPLP
- 0.57 % $ 756 M usaUSA
Tejon Ranch Co. Tejon Ranch Co.
TRC
$ 16.55 0.79 % $ 444 M usaUSA